Plunkett Research Online: Albireo Pharma Inc

ALBIREO PHARMA INC (ALBO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of the drug reformulation technology......



Albireo Pharma Inc
Ticker: ALBO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 203 796-5000
Fax: 203 798-3601
Address: 10 Post Office Square
Suite 502
South Boston, MA 02109 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Thomas SheaCFO/Chief Accounting Officer/Treasurer
Paresh SoniChief Medical Officer
See More
Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of the drug reformulation technology......See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: